Metabolic syndrome, which is closely associated with PCOS, may be an indicator of breast cancer risk in post-menopausal women, according to new research.
A study, prepared by multiple organizations including the CROM cancer research center in Mercogliano, Italy, analyzed 777 patients and found a higher prevalence of metabolic syndrome symptoms among post-menopausal women with breast cancer (33%) when compared to post-menopausal women without breast cancer (19%).
In the age range of 55 to 65 years, 40% of the breast cancer cases had more than three metabolic syndrome features, which can range from insulin resistance and high blood pressure to excess weight gain and high levels LDL “bad” cholesterol and triglyceride body fats.
Post-menopausal women show the highest incidence of breast cancer in the general female population.
More on the apparent link between metabolic syndrome and breast cancer tomorrow.